News
We send the latest information from SMC Laboratories.
BioJapan – join us!
We will be attending the annual 24th BioJapan from Wednesday, October 13th, 2021 – Friday, October 15th, 2021 (10/13 – 15, 2021) at the Pacifico Yokohama Convention Center! We are also going to give a formal convention presentation on the third day, Friday, October 15th, 2021 (10/15/2021). We would love to have the opportunity…
Lung fibrosis in COVID-19
COVID-19 is now being recognized as a multi-organ disease that causes not only pneumonia, but also cause damage to other organs such as the liver, kidney and intestines. Recent reports have focused on lung fibrosis. COVID-19 develops via infection with a virus belonging to the beta-coronavirus class, similar to the virus that…
ENYO Pharma announces positive Vonafexor (EYP001) results for the LIVIFY phase 2a study in F2-F3 NASH patients over 12 weeks
ENYO Pharma (France) announced on 28 July, 2021, positive Vonafexor (EYP001) results for the LIVIFY phase 2a study in F2-F3 NASH patients over 12 weeks. For detailed information, see the URL below. https://www.businesswire.com/news/home/20210728005557/en/ENYO-Pharma-Announces-Positive-Vonafexor-EYP001-Results-for-the-LIVIFY-Phase-2a-Study-in-F2-F3-NASH-Patients-over-12-weeks Vonafexor is a synthetic non-steroidal, non-Bile Acid, highly selective FXR agonist. This is used the STAM™ mouse model for non-clinical…
National Defense Medical College's publication in Surgery Open Science
SMC announces that National Defense Medical College (Japan) has published the results of a study using STAM™ mouse model in Surery Open Science. Title: “In vivo diffuse reflectance spectroscopic analysis of fatty liver with inflammation in mice” In this paper, they report the usefulness of diffuse reflectance spectroscopy, which does not require tissue collection,…
The virtual 81st Scientific Sessions of the American Diabetes Association® and updated information on our original NASH-HCC model (STAM™)
We recently made a presentation on our STAM™ mouse at the 81st Annual Meeting of the American Diabetes Association (June 25 to 29, 2021). The abstract of the presentation has been published in Diabetes. 209-LB: RNA-Seq Analysis of Liver from Diabetic and NASH Model Mouse Treated with Streptozotocin, High-Fat Diet | Diabetes (diabetesjournals.org)
Introducing our new model: Liver Orthotopic Xenograft mouse model
We’re getting in touch today with an announcement regarding the addition of the Liver Orthotopic Xenograft mouse model to our model line-up – a cancer model that also allows the evaluation of the tumor microenvironment. The number of deaths from cancer continues to rise as medical advances extend life spans. Therefore, there is a…
Our clients’ presentations at DDW 2021
Our clients presented data on treatment of NASH using STAMTM model at the DDW2021 (May 21-23). For detailed information, see the below URL. https://ddw.org/attendee-planning/online-planner/ Poster #Sa373 BOFUTSUSHOSAN, A TRADITIONAL JAPANESE MEDICINE, MAINTAINS THE GUT MICROBIOME AND AMELIORATES PROGRESSION OF LIVER DISORDER IN DIABETES INDUCED NASH MODEL MICE Institution: Hokkaido University (Japan)
SMC announces Presentation of New Data at the 81st Annual Meeting of the American Diabetes Association
We are pleased to announce the acceptance of our abstract, “RNA-seq Analysis of Liver from Diabetic and NASH Model Mouse Treated with Streptozotocin, High-Fat Diet”, for presentation in the category “Integrated Physiology—Liver” at the 81st Annual Meeting of the American Diabetes Association, to be held from June 25 to 29, 2021. The poster will…
Visit SMC Laboratories at BIO Digital 2021
We are joining the world’s largest virtual biotech partnering and education event, convening thousands of global biotech leaders and innovators. The virtual gathering of the global biotech industry provides access to key partners via BIO One-on-One Partnering, educational resources, and the valuable insights for research and development. Main Conference Webpage SMC Laboratories Inc's…
New Partnership with cancer model search service Repositive, Inc.
SMC Laboratories, Inc. is pleased to announce a partnership with Repositive, Inc., a UK-based bespoke cancer model search service. Repositive supports researchers working in oncology to find the right cancer models for their studies. They also organise and curate cancer model data from partner CROs, and present this inventory of models online, via their beta…